Home301333 • SHE
add
R&G PharmaStudies Co Ltd
Previous close
¥44.52
Day range
¥43.92 - ¥44.80
Year range
¥33.05 - ¥73.08
Market cap
4.25B CNY
Avg Volume
3.18M
P/E ratio
29.27
Dividend yield
-
Primary exchange
SHE
Market news
Financials
Income Statement
Revenue
Net income
(CNY) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 172.84M | -2.53% |
Operating expense | 40.12M | -14.32% |
Net income | 26.07M | 13.12% |
Net profit margin | 15.09 | 16.08% |
Earnings per share | — | — |
EBITDA | 24.95M | -3.76% |
Effective tax rate | 9.47% | — |
Balance Sheet
Total assets
Total liabilities
(CNY) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.71B | 0.49% |
Total assets | 2.28B | 3.46% |
Total liabilities | 417.16M | -3.25% |
Total equity | 1.87B | — |
Shares outstanding | 95.14M | — |
Price to book | 2.27 | — |
Return on assets | 2.49% | — |
Return on capital | 3.04% | — |
Cash Flow
Net change in cash
(CNY) | Mar 2025info | Y/Y change |
---|---|---|
Net income | 26.07M | 13.12% |
Cash from operations | -11.19M | -148.04% |
Cash from investing | -241.50M | -24.09% |
Cash from financing | -45.42M | -390.80% |
Net change in cash | -298.29M | -65.33% |
Free cash flow | -28.80M | -788.80% |
About
Founded
Aug 22, 2008
Website
Employees
2,208